Medical Properties Trust, Inc.
NYSE:MPW
4.34 (USD) • At close January 22, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,543 | 1,545 | 1,249 | 854 | 785 | 705 | 541 | 442 | 313 | 243 | 201 | 143 | 122 | 130 | 118 | 96 | 50 | 32 | 11 |
Cost of Revenue
| 46 | 39 | 25 | 24 | 9 | 6 | 3 | 4 | 2 | 2 | 1 | 1 | 4 | 6 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 1,497 | 1,506 | 1,224 | 830 | 775 | 699 | 538 | 438 | 311 | 240 | 200 | 142 | 117 | 124 | 118 | 96 | 50 | 32 | 11 |
Gross Profit Ratio
| 0.97 | 0.97 | 0.98 | 0.97 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.96 | 0.95 | 1 | 1 | 1 | 1 | 1 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 160 | 146 | 132 | 96 | 80 | 59 | 49 | 44 | 37 | 30 | 29 | 27 | 29 | 21 | 24 | 16 | 10 | 8 | 5 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 160 | 146 | 132 | 96 | 80 | 59 | 49 | 44 | 37 | 30 | 29 | 27 | 29 | 21 | 24 | 16 | 10 | 8 | 5 |
Other Expenses
| 333 | 321 | 264 | 152 | 133 | 125 | 94 | 70 | 54 | 37 | 34 | 33 | 24 | 26 | 26 | 13 | 7 | 4 | 0 |
Operating Expenses
| 493 | 467 | 396 | 249 | 213 | 184 | 143 | 114 | 91 | 67 | 62 | 60 | 53 | 47 | 50 | 28 | 17 | 12 | 7 |
Operating Income
| 735 | 986 | 850 | 561 | 562 | 486 | 342 | 263 | 143 | 154 | 132 | 77 | 52 | 77 | 68 | 68 | 34 | 19 | 4 |
Operating Income Ratio
| 0.48 | 0.64 | 0.68 | 0.66 | 0.72 | 0.69 | 0.63 | 0.6 | 0.46 | 0.63 | 0.66 | 0.54 | 0.43 | 0.59 | 0.58 | 0.71 | 0.67 | 0.61 | 0.34 |
Total Other Income Expenses Net
| 224 | -255 | -387 | -187 | 457 | -192 | -123 | -122 | -92 | -64 | -57 | -19 | -19 | -77 | -33 | -27 | -3,415,960 | 513 | 0 |
Income Before Tax
| 960 | 731 | 463 | 374 | 1,019 | 294 | 219 | 141 | 51 | 90 | 75 | 19 | 13 | 0 | 34 | 41 | 30,159,698 | 19,640 | 0 |
Income Before Tax Ratio
| 0.62 | 0.47 | 0.37 | 0.44 | 1.3 | 0.42 | 0.4 | 0.32 | 0.16 | 0.37 | 0.37 | 0.14 | 0.11 | 0 | 0.29 | 0.43 | 597,559.78 | 622.53 | 0 |
Income Tax Expense
| 56 | 74 | 31 | -3 | 1 | 3 | -7 | 2 | 0 | 1 | 1 | 37 | 42 | -36 | 0 | 0 | -3,415,957 | 512 | -1 |
Net Income
| 903 | 656 | 431 | 375 | 1,017 | 290 | 225 | 140 | 51 | 97 | 90 | 27 | 23 | 36 | 34 | 41 | 30 | 20 | 5 |
Net Income Ratio
| 0.59 | 0.42 | 0.35 | 0.44 | 1.3 | 0.41 | 0.42 | 0.32 | 0.16 | 0.4 | 0.45 | 0.19 | 0.19 | 0.28 | 0.29 | 0.43 | 0.6 | 0.62 | 0.42 |
EPS
| 1.51 | 1.11 | 0.81 | 0.87 | 2.78 | 0.82 | 0.86 | 0.64 | 0.29 | 0.64 | 0.67 | 0.23 | 0.22 | 0.45 | 0.5 | 0.86 | 0.76 | 0.61 | 0.24 |
EPS Diluted
| 1.51 | 1.11 | 0.81 | 0.87 | 2.78 | 0.82 | 0.86 | 0.63 | 0.29 | 0.63 | 0.67 | 0.23 | 0.22 | 0.45 | 0.5 | 0.86 | 0.76 | 0.61 | 0.24 |
EBITDA
| 1,068 | 1,307 | 1,115 | 713 | 1,382 | 601 | 475 | 334 | 204 | 203 | 184 | 118 | 108 | 103 | 93 | 81 | 42 | 24 | 5 |
EBITDA Ratio
| 0.69 | 0.85 | 0.89 | 0.84 | 1.76 | 0.85 | 0.88 | 0.76 | 0.65 | 0.84 | 0.91 | 0.82 | 0.88 | 0.79 | 0.79 | 0.84 | 0.83 | 0.75 | 0.48 |